FDA classifies Inventia Healthcare chlorthalidone recall as Class II

FDA classifies Inventia Healthcare chlorthalidone recall as Class II

Health

The U. S.

Food and Drug Administration classified the recall of Inventia Healthcare Limited’s 25-mg chlorthalidone tablets as a Class II action on September 29, after quality tests showed the tablets failed to dissolve properly. Inventia Healthcare had voluntarily recalled 13,567 bottles of the medication on September 17, following FDA testing that indicated the tablets did not meet dissolution standards.

Actors

U.S. Food and Drug Administration Inventia Healthcare Limited Jennifer Young, PharmD Institute for Safe Medication Practices

Locations

United States

Articles

September 29, 2026
2 total
Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets
Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets

Fox Business • 29 Sep 20:05

The FDA classified the recall of Inventia Healthcare's 25-mg chlorthalidone tablets as a Class II action after quality tests showed the tablets did not dissolve properly.

Credibility 78% Manip. 8% Center
Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets due to failed dissolution tests
Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets due to failed dissolution tests

New York Post • 29 Sep 13:49

Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets after FDA testing showed they did not meet dissolution standards, marking the company's second Class II recall this year.

Credibility 78% Manip. 8% Center
September 27, 2026
3 total
FDA Classifies September Chlorthalidone Recall as Class II
FDA Classifies September Chlorthalidone Recall as Class II

Yahoo • 27 Sep 17:06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

Credibility 78% Manip. 8% Center
FDA Classifies September Chlorthalidone Recall as Class II
FDA Classifies September Chlorthalidone Recall as Class II

Yahoo News Singapore • 27 Sep 17:06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

Credibility 78% Manip. 5% Center
FDA Classifies September Chlorthalidone Recall as Class II
FDA Classifies September Chlorthalidone Recall as Class II

AOL.com • 27 Sep 17:06

The FDA has designated a September recall of Inventia Healthcare's chlorthalidone tablets as a Class II recall, citing failed dissolution specifications.

Credibility 72% Manip. 7% Center
September 24, 2026
1 total
FDA issues Class II recall of over 13,000 bottles of chlorthalidone
FDA issues Class II recall of over 13,000 bottles of chlorthalidone

AOL.com • 24 Sep 16:34

The U.S. Food and Drug Administration has recalled more than 13,000 bottles of the blood-pressure drug chlorthalidone after dissolution tests failed, urging patients to consult their providers.

Credibility 78% Manip. 8% Center

Related events